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Keratitis±ichthyosis±deafness syndrome is a rare dis-
order characterized by erythrokeratoderma, deafness,
and keratitis. Scarring alopecia and squamous cell
carcinoma can also occur. Most cases described so
far were sporadic. Here we present evidence that
keratitis±ichthyosis±deafness syndrome is caused by a
mutation in the connexin 26 gene. This ®nding
expands the spectrum of disorders caused by defects
in connexin 26 and implies the gene in normal cor-
neal function, hair growth, and carcinogenesis. Key
words: skin cancer/alopecia/gap junction. J Invest
Dermatol 118:724±727, 2002
K
eratitis±ichthyosis±deafness (KID) syndrome is a rare
autosomal dominant disorder. It is characterized by
the occurrence of localized erythematous scaly skin
lesions, severe bilateral keratitis, and sensorineural
deafness (Rycroft et al, 1976; Cram et al, 1979;
Skinner et al, 1981; Singh, 1987; Langer et al, 1990; McGrae, 1990;
Morris et al, 1991; Nurse, 1994; Caceres-Rios et al, 1996; Alli and
Gungor, 1997; Kone-Paut et al, 1998). The term ``ichthyosis'' is,
strictly speaking, not correct, as the skin lesions are more
appropriately classi®ed as erythrokeratoderma.
A scarring alopecia can be part of the phenotype. The skin
lesions occur predominantly on the face, palms, and soles, and have
a typical reticulated pattern that is often called leather-like.
Squamous cell carcinoma has been reported in 11% of the patients
and may probably be considered as a manifestation of the disease
(Grob et al, 1987; Madariaga et al, 1986; Hazen et al, 1989, 1992;
Morris et al, 1991). Histologic examination usually shows
nonspeci®c changes but may show severe follicular plugging.
The combination of erythrokeratoderma and deafness also occurs
in erythrokeratoderma variabilis of Mendes da Costa, an autosomal
dominant disorder that has been shown to be caused by mutations
in the connexin (CX) genes 30.3 and 31 (Richard et al, 1998;
Wilgoss et al, 1999; Kelsell et al, 2000). Although keratitis is not part
of erythrokeratoderma variabilis, the skin lesions and sensorineural
deafness are similar to those found in KID syndrome. Therefore,
we considered the connexin genes that are expressed in skin
excellent candidates for KID syndrome.
We ascertained a patient suffering from KID syndrome. She is
the only affected person in the family (Cremers et al, 1977). The
patient, the youngest of nine children, was born at term from
consanguineous (third degree) Dutch parents. Pregnancy was
uneventful. During the ®rst weeks after birth, thickening and
scaling of the skin became apparent, as well as a reddish-brown
discoloration of affected skin. The patient reportedly had trouble
sweating. At 4 y of age, the parents ®rst noted hearing loss.
Psychomotor development was normal. From 11 y of age, the
patient developed bilateral keratitis with photophobia. Repeated
keratoconjunctivitis with super®cial and deep neovascularization of
both lenses necessitated the implantation of arti®cial lenses at age
34. This intervention in turn induced a bullous corneal dystrophy.
At 38 y of age, she developed a skin lesion on the right ankle that
was initially diagnosed as pseudo-epitheliomatous hyperplasia.
Later, the diagnosis was revised as spinocellular carcinoma. The
lesion was excised and the patient remains free of disease to date.
Physical examination at age 18 showed red, hyperkeratotic skin
on much of the body surface. The nails of hands and feet were
thickened. Scalp hair was brittle, eyebrows and eyelashes were
sparse, whereas pubic and axillary hair were missing altogether.
Mammary gland development was insuf®cient for age (Fig 1).
Dentition was abnormal; the teeth were small and abnormally
shaped. Ophthalmologic examination showed bilateral bullous
corneal dystrophy with neovascularization. Bilateral astigmatism
was noted as well. Audiologic examination demonstrated profound
bilateral sensorineural hearing loss. No other abnormalities were
noted and a karyotype was a normal 46,XX.
Blood was taken from the patient, her mother, and four sibs, and
DNA extracted from peripheral blood leukocytes using methods
described elsewhere (Miller et al, 1988). The father was deceased.
We sequenced connexin genes that are known or expected to be
involved in skin disorders and sometimes accompanied by deafness.
The genes that were analyzed are CX26 (GJB2), 30 (GJB6), 30.3
(GJB3), 31 (GJB5), 31.1 (GJB4), and 37 (GJA4). We did not
sequence CX43. It is expressed in skin (Goliger and Paul, 1994),
but has been implicated mainly in cardiac morphogenesis and
function (Huang et al, 1998) and lens function (Gao and Spray,
1998).
Primer sequences were as follows: Cx26F, GCATGCTTGCT-
TACCCAGACTC; Cx26R, AGGGGAGCAGAGCTCCATTG;
Cx30F, AGCAGGGCAGGGAGTTGAAG; Cx30R, TCAGGT-
TGGTATTGCCTTCTGG; Cx30.3F, CAATCGCACCAG-
CATTAAGGG; Cx30.3R, TGATCTTATCTGCTGATCTCG-
CAG; Cx31F, TTCATTCATACGATGGTTTTTCCTC;
Cx31R, ACCTCTCCACCTGCCACACC; Cx31.1F, GAA-
CCCAGCTCCTCTAGTGATGG; Cx31.1R, CCATCCAGG-
CCCAACCTG. The sequences were assembled and analyzed
using the Phred-Phrap-Consed software tools (Ewing and Green,
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1998; Ewing et al, 1998; Gordon et al, 1998). No mutations were
found in CX30, CX30.3, CX31, and CX31.1. In CX26 the patient
had a heterozygous GAC to AAC change in codon 50. This
changes a conserved aspartic acid into an asparagine in the ®rst
extracellular domain (D50N). Because the G to A change abolishes
an AspI (Roche Diagnostics, DE-68305 Mannheim, Germany)
restriction site, we examined controls and the family by restriction
analysis. The mutation was not present in 164 control alleles and
could not be demonstrated in the mother and four sibs either
(Fig 2). The absence in 164 control alleles and the other family
members strongly suggests that it is not a polymorphism; however,
recent evidence suggests that some disorders associated with
connexin mutations can be digenic. Kelsell et al (2000) have
demonstrated that a variation in CX26 (M34T) can interact with
mutations in CX26 and CX31 to produce a more severe hearing
loss than occurs in single CX26/31 mutants. It is possible that a
similar phenomenon is at work in KID syndrome, explaining its
rarity and the relative lack of instances with autosomal dominant
inheritance. We did not ®nd mutations in CX30, CX30.3, CX31,
CX31.1, and CX37 or in the other CX26 allele, suggesting that in
this particular case a digenic mutation is less likely. The ®nding of
this novel mutation expands the spectrum of disorders in which
CX26 is involved. So far, it has been implicated in a variant of
Vohwinkel's syndrome (MIM 124500), palmoplantar keratoder-
ma±deafness syndrome and nonsyndromic hearing loss.
The aspartic acid at position 50 is conserved across species and
across the connexins suggesting that it is of vital importance for
correct functioning of the protein (Fig 3). It has been demon-
strated that a substitution in CX26 (W77R) impairs transport of
small charged molecules across gap junctions (White, 2000). This
mutation also leads to inef®cient targeting of the protein product to
the plasma membrane with subsequent retention in intracellular
stores. In addition, the mutated connexin showed limited
oligomerization into connexon hemichannels. It is tempting to
speculate that the KID syndrome mutation has a similar effect;
however, the W77R mutation is recessive, suggesting that the KID
mutation must have additional effects.
As the D50N change replaces a charged amino acid by an
uncharged one, the substitution can be expected to affect local
conformation. It may also in¯uence voltage gating. Recent data
suggest that single gene mutations may affect voltage-dependent
gating in heterotypic channels such as those formed by CX26 and
CX32 (Zhao and Santos-Sacchi, 2000). In addition, the introduc-
tion of charge at the start of the ®rst extracellular loop can be
expected to disturb local conformation and thus interfere with
docking to the partner connexin. It has been demonstrated that
local E1 topology is essential for connexon formation (Foote et al,
1998). The clustering of skin disease associated CX26 mutations in
this domain suggests that this domain is of special importance in
skin, either for skin-speci®c connexon assembly or for interactions
with other proteins. In other connexins, the mutations causing
erythrokeratoderma variabilis are clustered in the ®rst transmem-
brane domain, supporting the hypothesis that the CX26 E1 domain
has a special function in skin physiology. This issue needs to be
addressed in future studies.
Of interest is the role for CX26 in the cornea that is suggested by
our ®ndings. The main gap junction protein in the cornea seems to
be CX43 (Nishida et al, 1996). No CX26 expression has so far been
found in corneal epithelium from many animal species (White and
Bruzzone, 2000); however, human cornea has to our knowledge
not yet been examined for CX26 expression.
Homozygous CX43 knockout mice have lens abnormalities
consisting of separation and vacuolization of lens ®brils, interpreted
as early signs of cataract (Gao and Spray, 1998). Apparently, this
connexin is required for maintenance of osmotic pressure in the
lens. It is tempting to speculate that CX26 has a similar role in the
human cornea. If corneal keratinocytes were to become separated,
infectious agents might be able to establish a presence in between
the corneocytes. This would lead to keratitis. Other disorders
caused by CX26 mutations are not accompanied by overt corneal
disease. Skin symptoms, however, are associated with particular
mutations and it is conceivable that the same applies to corneal
involvement in which case the communication or osmotic pressure
hypotheses would not be tenable as sole explanation. It would be of
considerable interest to examine other forms of corneal dystrophy
for connexin mutations in order to test this assertion.
Figure 1. Phenotype of the patient. (A) Typical shark-skin-like
hyperkeratosis and erythroderma on left calf and ankle. (B) Hypotrichosis
and hyperkeratosis in right axilla. (C) Frontal view of patient. Mask-like
erythrokeratoderma of the face, lack of pubic hair, pronounced
erythroderma of extremities with sparing of rump. Vestigial mammary
glands.
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The scarring alopecia observed in KID syndrome is probably
related to the follicular plugging that is commonly observed. A role
for CX26 in hair follicle differentiation is suggested by the
hypotrichosis observed elsewhere on the body. Thus far, only
CX30 has been implicated in hair growth. This aspect of the
phenotype is likely related to the speci®c mutation we observe
here, as other disorders caused by CX26 mutations are not
characterized by hypotrichosis. Thus, as in the case of the keratitis,
it is not likely that the hypotrichosis is related solely to a disturbance
of intercellular communication. The same can be said for the
propensity for developing squamous cell carcinomas, which is
observed in KID syndrome but not in other disorders caused by
connexin mutations. CX26 is known to be reduced or absent in
mammary carcinoma cells and is considered a putative tumor
suppressor for epithelial tumors (Lee et al, 1991, 1992; Tu et al,
1998; Singal et al, 2000). Other connexins such as CX37 have been
shown to be involved in tumorigenesis. Speci®cally, CX37
mutations have been described in vinyl chloride induced hepatic
angiosarcomas (Saito et al, 1997) and disturbed gap junction
communication has been reported in many other tumor types.
CX32 mutant mice are prone to liver cancer (Moennikes et al,
2000). No de®nite connexin mutations have been reported in
human cancers or cancer-prone disorders. Our ®ndings are the ®rst
to suggest that germline connexin mutations can lead to skin cancer
in humans.
CX26 is known to upregulate E-cadherin expression (Stoler et al,
1993). As E-cadherin is probably involved in the regulation of hair
growth (Van Steensel et al, 2000, 2001) and is downregulated in
approximately 70% of squamous cell carcinomas examined in one
study (Koseki et al, 1999) it is likely that alterations of E-cadherin
expression are involved in the increased cancer susceptibility and
hypotrichosis of KID syndrome.
In conclusion, the ®nding of a novel CX26 mutation in KID
syndrome supports the notion that connexins have functions not
directly related to their presence in gap junctions and demonstrates
that germ-line connexin mutations can cause cancer in humans. It
appears that deafness and erythroderma are symptoms that may be
related to disturbed gap junction function per se. Other symptoms
such as the keratitis and the cancer-proneness seem to be dependent
upon mutations in a particular residue suggesting that disturbance
of gap junction formation is not suf®cient as an explanation and that
there may be direct interactions with the cytoskeleton or cell-cycle
machinery dependent upon speci®c amino acid motifs in the
connexin protein.
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